Title of the centre:
WHO Collaborating Centre for Smallpox Vaccine
Director / Head:
Prof. dr. mrs M.C.J.P. Boog
Dr Willem Luytjes
Institution:
Netherlands Vaccine Institute (NVI)
Ministry of Health, Welfare and Sport
Address:
P.O. Box 457, Antonie van Leeuwenhoeklaan 11
NL-3721 MA
Town:
Bilthoven
Country:
NETHERLANDS
Region:
EURO
Phone:
(31-30) 274 8563/7520
Fax:
(31-20) 274 4439
Date of Designation:
01/Jan/1969
Last Redesignation:
27/May/2009
Expiry:
27/May/2013
Date of Discontinuation:
Terms of Reference:
- To hold vaccinia seed virus & reference materials required for the production, potency testing & quality control of smallpox vaccine. Make these materials available at the request of WHO.
- To distribute vaccinia seed virus & other reference materials on the advice & approval of WHO.
- To undertake arrangements for replenishing vaccinia seed stocks when necessary.
- To undertake collaborative activities to assess the quality & characteristics of vaccinia seed stocks.
- To test batches of smallpox vaccine from the WHO vaccine reserves according to agreed upon criteria & schedule within the designation period.
- To set up a smallpox vaccine information centre in which information on smallpox vaccine is collected & stored.
- To have trained and properly vaccinated personel available to carry out the tasks described in TOR 1-5.
- To underpin WHO with the logistics of emergency vaccination against smallpox.
-
-
Subjects:
- Vaccines
- Smallpox
-
Types of activity:
- Product development (guidelines; manual; methodologies; etc.)
- Information dissemination
- Research
WHO organization wide expected result:
| |
1.4 - Policy and technical support provided to Member States in order to enhance their capacity to carry out surveillance and monitoring of all communicable diseases of public health importance. |
| |
1.7 - Member States and the international community equipped to detect, assess, respond to and cope with major epidemic and pandemic-prone diseases (e.g. influenza, meningitis, yellow fever, haemorrhagic fevers, plague and smallpox) through the development and implementation of tools, methodologies, practices, networks and partnerships for prevention, detection, preparedness and intervention. |
| |
1.8 - Regional and global capacity coordinated and made rapidly available to Member States for detection, verification, risk assessment and response to epidemics and other public health emergencies of international concern. |
Responsible Officer:
COSTA Alejandro Javier
Phone:
+41 22 79 14965
Technical Counterpart:
GAVRILIN Evgeniy
Phone:
+45 39171574
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork
|